30 Day Trial

Seikagaku up 5.9% in 2Q19 on US Reimbursement

Share:

Seikagaku reports FY 1Q19 revenue of ¥7,649MM (USD $69.1MM), +5.9% vs. FY 1Q18.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.